Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
 Shares Announced by Shareholders Foundation - EconoTimes)
SAN DIEGO, Jan. 27, 2016 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York on behalf of certain investors who purchased of shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) over alleged Securities Laws Violations by Anavex Life Sciences.
Investors who purchased shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) have certain options and for certain investors are short and strict deadlines running. Deadline: February 29, 2016. (NASDAQ:AVXL) investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff claims that the defendants made certain allegedly false and/or misleading statements and/or allegedly failed to disclose that Anavex had used a paid stock promoter to artificially inflate the Company’s share price and that as a result of the foregoing, Anavex’s public statements were materially false and misleading at all relevant times.
On December 29, 2015, Anavex Life Sciences Corp. disclosed that it had received a subpoena from the U.S. Securities and Exchange Commission (“SEC”) on December 22, 2015. Anavex Life Sciences Corp. stated, in part, that "[t]he Company believes the subpoena and investigation relate to the recent unusual activity in the market for the Company's shares."
On December 30, 2015, a report was published entitled “Anavex: A Regulatory Target Damaged By Incriminating Evidence.”
Those who purchased (NASDAQ:AVXL) shares have certain options and should contact the Shareholders Foundation, Inc. by e-mail at [email protected] or call +1 (858) 779-1554.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
